Many novel therapies are hindered by the poor properties of the investigational drugs, which can be addressed through drug delivery technologies to target them to where they should be in the body to exert their novel pharmacological effects.

The Li Lab is committed to enabling novel therapeutics through innovating targeted drug delivery technologies. We specialize in nanoparticle and prodrug technologies. We synthesize novel polymers, lipids and drug conjugates, and use innovative engineering techniques to formulate them into nanoparticles or human-friendly dosage forms that can be better absorbed and target to specific tissues and cells. We focus on drugs that are challenged with delivery issues and diseases that are poorly treated with currently available medications. Our proprietary technologies transform these drugs to be safe, effective, and novel therapies to address unmet medical needs.